BCYC vs TFC · rev $1.5M vs rev $11.82B
Bicycle Therapeutics Ltd (BCYC) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
BCYC currently screens at market cap $554.0M. TFC currently screens at market cap $0.
Not investment advice. Open the BCYC and TFC stock pages for the full models.
Not investment advice.